COMP <GO>
ZYME vs SDGR // REVENUE GROWTH (YOY)
Zymeworks Inc. (NASDAQ) VS. Schrodinger Inc. (NASDAQ) • 15-METRIC TALLY: ZYME 4
— SDGR 4
▲ REVENUE GROWTH (YOY) LEADER: ZYME
LAST: $28.99 (+1.33%) • MKT CAP: $2.02B
revenue-growth
38.90%
LAST: $26.19 (-3.50%) • MKT CAP: $2.03B
revenue-growth
23.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZYME VS. SDGR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZYME | SDGR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 55.70% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.20% | -35.00% | +2.80 | ZYME | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.71% | 0.56% | -2.27 | SDGR | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -40.40% | -19.60 | SDGR | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 38.90% | 23.30% | +15.60 | ZYME | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.85 | 2.64 | +9.21 | ZYME | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | SDGR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.0 | 51.8 | +8.20 | ZYME | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.02B | $2.03B | -$13.9M | SDGR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZYME REV | SDGR REV | ZYME GROSS % | SDGR GROSS % | ZYME FCF | SDGR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $106.0M | $255.9M | — | 55.7% | -$34.5M | $12.5M |
| FY 2024 | $76.3M | $207.5M | — | 63.6% | -$112.0M | -$164.7M |
| FY 2023 | $76.0M | $216.7M | — | — | -$118.3M | -$136.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZYME // BETA —
SDGR // BETA —